共 93 条
[1]
Vodovotz Y., Constantine G., Rubin J., Csete M., Voit E.O., An G., Mechanistic simulations of inflammation: Current state and future prospects, Math Bioscie, 217, 1, pp. 1-10, (2009)
[2]
Nathan C., Points of control in inflammation, Nature, 420, 6917, pp. 846-852, (2002)
[3]
Schlag G., Redl H., Mediators of injury and inflammation, World J Surg, 20, 4, pp. 406-410, (1996)
[4]
Matzinger P., The danger model: A renewed sense of self, Science, 296, 5566, pp. 301-305, (2002)
[5]
Santos C.C., Zhang H., Liu M., Slutsky A.S., Bench-to-bedside review: Biotrauma and modulation of the innate immune response, Crit Care, 9, 3, pp. 280-286, (2005)
[6]
Medzhitov R., Origin and physiological roles of inflammation, Nature, 454, 7203, pp. 428-435, (2008)
[7]
Oviedo J.A., Wolfe M.M., Clinical potential of cyclo-oxygenase-2 inhibitors, BioDrugs, 15, 9, pp. 563-572, (2001)
[8]
Borer J.S., Simon L.S., Cardiovascular and gastrointestinal effects of COX-2 inhibitors and NSAIDs: Achieving a balance, Arthritis Res Ther, 7 SUPPL. 4, (2005)
[9]
Rychly D.J., Dipiro J.T., Infections associated with tumor necrosis factor-alpha antagonists, Pharmacotherapy, 25, 9, pp. 1181-1192, (2005)
[10]
Calabrese L., The yin and yang of tumor necrosis factor inhibitors, Cleve Clin J Mede, 73, 3, pp. 251-256, (2006)